Palisades Park, New Jersey Clinical Trials

A listing of Palisades Park, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 517 clinical trials
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

myeloid leukemia
cancer therapy
myelodysplastic syndromes
recurrent disease
exhausted
Memorial Sloan-Kettering Cancer Center
 (5.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
TKR With and Without the Use of Intra-operative Sensing

The purpose of this study is to determine if there is a difference in clinical outcomes after total knee replacement (TKR) performed with traditional ligament balancing compared to use of intraoperative sensing technology (IOS) to balance ligaments. IOS is used to send real time information to a monitor within the …

osteoarthritis
total knee replacement
Hospital for Special Surgery
 (5.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

liquid biopsy
folic acid
adjuvant therapy
stage iv non-small cell lung cancer
pemetrexed
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

coagulation disorder
dipg
side effects of drugs
platelet count
glioma
Columbia University Irving Medical Center
 (2.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

core needle biopsy
oophorectomy
drug test
lung adenocarcinoma
tubal ligation
Icahn School of Medicine at Mount Sinai
 (4.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

fallopian tube
metastasis
line of therapy
platelet count
prostate cancer
Memorial Sloan-Kettering Cancer Center
 (5.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy

Endocrine therapy is the initial treatment for most hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancers. This study will evaluate the use of venetoclax in combination with capecitabine in adult participants with HR+, HER2-, metastatic breast cancer (MBC) who had disease progression following treatment …

epidermal growth factor
venetoclax
primary tumor
capecitabine
erbb2
Memorial Sloan Kettering Cancer Center /ID# 214886
 (5.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +15 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

egf receptors
epidermal growth factor
anaplastic lymphoma
stage iv non-small cell lung cancer
drug test
Hackensack Univ Med Ctr /ID# 216484
 (3.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death

Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart …

heart transplantation
NYU Langone Health
 (6.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

The investigators are doing this study to find out whether lowering the dose of postoperative radiation therapy and targeting a smaller area of tissue for treatment is as effective as the standard dose and volume of radiation therapy to control soft tissue sarcoma after surgery. They also want to find …

serum pregnancy test
sarcoma of the extremity
primary tumor
sarcoma
soft tissue sarcoma
Memorial Sloan Kettering Cancer Center
 (5.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations